The effect of Tranexamic acid administration on non-traumatic Intracerebral hemorrhage in contrast with placebo

Phase 3

Recruiting

• Conditions: Intraparanchymal hemorrhage.; Nontraumatic intracerebral hemorrhage in hemisphere, subcortical; I61.0

• Registration Number: IRCT20220520054927N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age between 18-75 years old
Acute non-traumatic intra-paranchimal hemorrhage
Less than 12 hours since bleeding

Exclusion Criteria

Multiple intra-paranchimal hemorrhage
Contraindication for Anti-phybrinolytic treatment
Massive ntra-paranchimal hemorrhage (>70cc)
Stem ICH
cerebral aneurysm or vascular anomalies
Post CVA hemorrhagic formation
Cerebral venous thrombosis
Anti-thrombolytic therapy
Brain tumor or infection

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expansion of intraparanchymal hemorrhage. Timepoint: Before intervention, 1 and 3 days later. Method of measurement: Brain CT scan.